JPMorgan Chase & Co. Lowers H.B. Fuller (NYSE:FUL) Price Target to $60.00

H.B. Fuller (NYSE:FUL) had its target price decreased by equities research analysts at JPMorgan Chase & Co. from $70.00 to $60.00 in a report issued on Friday,Benzinga reports. The firm presently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 3.44% from the company’s previous close.

Other analysts have also issued reports about the stock. Citigroup dropped their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. Vertical Research cut H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, H.B. Fuller has a consensus rating of “Hold” and a consensus price target of $84.20.

H.B. Fuller Stock Down 0.1 %

FUL opened at $62.14 on Friday. H.B. Fuller has a 12 month low of $60.96 and a 12 month high of $87.67. The company has a current ratio of 1.89, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10. The business’s 50-day moving average price is $70.82 and its 200-day moving average price is $76.79. The company has a market cap of $3.39 billion, a P/E ratio of 19.18, a P/E/G ratio of 1.50 and a beta of 1.43.

H.B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing the consensus estimate of $1.00 by ($0.08). The firm had revenue of $923.00 million during the quarter, compared to analysts’ expectations of $916.84 million. H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.32 earnings per share. On average, equities analysts expect that H.B. Fuller will post 3.84 EPS for the current year.

Hedge Funds Weigh In On H.B. Fuller

Institutional investors have recently bought and sold shares of the stock. Wesbanco Bank Inc. boosted its position in H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock valued at $924,000 after acquiring an additional 4,000 shares in the last quarter. S&CO Inc. boosted its position in shares of H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock valued at $21,209,000 after purchasing an additional 920 shares in the last quarter. Marshall Wace LLP grew its stake in H.B. Fuller by 9.9% in the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock worth $22,319,000 after purchasing an additional 26,239 shares during the period. Lord Abbett & CO. LLC raised its holdings in H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in H.B. Fuller by 1.5% during the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after buying an additional 18,734 shares during the period. 95.93% of the stock is owned by institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.